Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery

Bibliography

• WHO. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD. 2013. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf [cited 13 January 2014]
   Google Scholar
• WHO. Chronic obstructive pulmonary disease (COPD). 2013. Fact sheet N°315. Available from: http://www.who.int/mediacentre/factsheets/fs315/en/ [cited 13 January 2014]
   Google Scholar
• WHO. The global burden of disease: 2004 update. 2013. Available from: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf [cited 13 January 2014]
   Google Scholar
• Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370(9589):741-50
   PubMed Web of Science ®Google Scholar
• Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005;366(9500):1875-81
   PubMed Web of Science ®Google Scholar
• Lopez Varela MV, Montes de Oca M, Halbert R, et al. Comorbidities and health status in individuals with and without COPD in five latin american cities: the PLATINO study. Arch Bronconeumol 2013;49(11):468-74
   PubMed Web of Science ®Google Scholar
• WHO. World health statistics 2008. 2008. Available from: http://www.who.int/whosis/whostat/EN_WHS08_Full.pdf [cited 11 September 2012]
   Google Scholar
• WHO. Projections of mortality and causes of death, 2015 and 2030. Available from: http://www.who.int/entity/healthinfo/global_burden_disease/GHE_DthGlobal_Proj_2015_2030.xls [cited 14 January 2014]
   Google Scholar
• Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28(3):523-32
   PubMed Web of Science ®Google Scholar
• Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD? – Report from the obstructive lung disease in Northern Sweden studies. Respir Med 2003;97(2):115-22
   PubMed Web of Science ®Google Scholar
• Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009;374(9691):733-43
   PubMed Web of Science ®Google Scholar
• Toren K, Jarvholm B. Occupational exposure to vapors, gases, dusts and fumes and mortality in relation to chronic obstructive pulmonary disease among Swedish construction workers - a longitudinal cohort study. Chest 2013. [Epub ahead of print]
   Web of Science ®Google Scholar
• Ezzati M, Hoorn SV, Lopez AD, et al. Comparative quantification of mortality and burden of disease attributable to selected risk factors. Chapter 4. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global burden of disease and risk factors. Oxford University Press and The World Bank, Washington, DC; 2006
   Google Scholar
• Lopez Varela MV, Montes de Oca M, Halbert RJ, et al. Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 2010;36(5):1034-41
   PubMed Web of Science ®Google Scholar
• Silverman EK, Weiss ST, Drazen JM, et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162(6):2152-8
   PubMed Web of Science ®Google Scholar
• Foreman MG, Zhang L, Murphy J, et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med 2011;184(4):414-20
   PubMed Web of Science ®Google Scholar
• Gingo MR, Morris A, Crothers K. Human immunodeficiency virus-associated obstructive lung diseases. Clin Chest Med 2013;34(2):273-82
   PubMed Web of Science ®Google Scholar
• Lee CH, Lee MC, Lin HH, et al. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS One 2012;7(5):e37978
   PubMed Web of Science ®Google Scholar
• United Nations DoEaSA, Population Division. World Population Prospects: the 2012 Revision, Volume I: Comprehensive Tables ST/ESA/SER.A/336. 2013. Available from: http://esa.un.org/wpp/Documentation/pdf/WPP2012_Volume-I_Comprehensive-Tables.pdf [cited 18 February 2014]
   Google Scholar
• United Nations DoEaSA, Population Division. World Population Prospects: the 2012 Revision, Volume II: Demographic Profiles. ST/ESA/SER.A/345. 2013. Available from: http://esa.un.org/wpp/Documentation/pdf/WPP2012_Volume-II-Demographic-Profiles.pdf [cited 18 February 2014]
   Google Scholar
• Foreman MG, Campos M, Celedon JC. Genes and chronic obstructive pulmonary disease. Med Clin North Am 2012;96(4):699-711
   PubMed Web of Science ®Google Scholar
• Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet 2005;365(9478):2225-36
   PubMed Web of Science ®Google Scholar
• Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 2009;4:435-59
   PubMed Web of Science ®Google Scholar
• Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest 2012;122(8):2749-55
   PubMed Web of Science ®Google Scholar
• Schamberger AC, Mise N, Jia J, et al. Cigarette smoke-induced disruption of bronchial epithelial tight junctions is prevented by transforming growth factor-beta. Am J Respir Cell Mol Biol 2013. [Epub ahead of print]
   Google Scholar
• Heijink IH, Brandenburg SM, Postma DS, van Oosterhout AJ. Cigarette smoke impairs airway epithelial barrier function and cell-cell contact recovery. Eur Respir J 2012;39(2):419-28
   PubMed Web of Science ®Google Scholar
• Russo VEA, Martienssen RA, Riggs AD. Epigenetic mechanisms of gene regulation. Cold Spring Harbor Laboratory Press; Plainview, NY; 1996
   Google Scholar
• Puck JM, Willard HF. X inactivation in females with X-linked disease. N Engl J Med 1998;338(5):325-8
   PubMed Web of Science ®Google Scholar
• Talens RP, Christensen K, Putter H, et al. Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs. Aging Cell 2012;11(4):694-703
   PubMed Web of Science ®Google Scholar
• Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005;102(30):10604-9
   PubMed Web of Science ®Google Scholar
• Brix TH, Hegedus L. Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin Endocrinol (Oxf) 2012;76(4):457-64
   PubMed Web of Science ®Google Scholar
• Runyon RS, Cachola LM, Rajeshuni N, et al. Asthma discordance in twins is linked to epigenetic modifications of T cells. PLoS One 2012;7(11):e48796
   PubMedGoogle Scholar
• Givelber RJ, Couropmitree NN, Gottlieb DJ, et al. Segregation analysis of pulmonary function among families in the Framingham Study. Am J Respir Crit Care Med 1998;157(5 Pt 1):1445-51
   PubMed Web of Science ®Google Scholar
• Tager I, Tishler PV, Rosner B, et al. Studies of the familial aggregation of chronic bronchitis and obstructive airways disease. Int J Epidemiol 1978;7(1):55-62
   PubMed Web of Science ®Google Scholar
• Belinsky SA, Palmisano WA, Gilliland FD, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 2002;62(8):2370-7
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Reduced histone deacetylase in COPD: clinical implications. Chest 2006;129(1):151-5
   PubMed Web of Science ®Google Scholar
• Adcock IM, Tsaprouni L, Bhavsar P, Ito K. Epigenetic regulation of airway inflammation. Curr Opin Immunol 2007;19(6):694-700
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 2005;25(3):552-63
   PubMed Web of Science ®Google Scholar
• Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 2002;3(9):662-73
   PubMed Web of Science ®Google Scholar
• Qiu W, Baccarelli A, Carey VJ, et al. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med 2012;185(4):373-81
   PubMed Web of Science ®Google Scholar
• Liu F, Killian JK, Yang M, et al. Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 2010;29(25):3650-64
   PubMed Web of Science ®Google Scholar
• Monick MM, Beach SR, Plume J, et al. Coordinated changes in AHRR methylation in lymphoblasts and pulmonary macrophages from smokers. Am J Med Genet B Neuropsychiatr Genet 2012;159B(2):141-51
   PubMed Web of Science ®Google Scholar
• Vucic EA, Chari R, Thu KL, et al. DNA methylation is globally disrupted and associated with expression changes in COPD small airways. Am J Respir Cell Mol Biol 2013. [Epub ahead of print]
   Google Scholar
• Phillips JM, Goodman JI. Inhalation of cigarette smoke induces regions of altered DNA methylation (RAMs) in SENCAR mouse lung. Toxicology 2009;260(1-3):7-15
   PubMed Web of Science ®Google Scholar
• Breton CV, Byun HM, Wenten M, et al. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med 2009;180(5):462-7
   PubMed Web of Science ®Google Scholar
• Hollams EM, de Klerk NH, Holt PG, Sly PD. Persistent effects of maternal smoking during pregnancy on lung function and asthma in adolescents. Am J Respir Crit Care Med 2014;189(4):401-7
   PubMed Web of Science ®Google Scholar
• Georgiou E, Valeri R, Tzimagiorgis G, et al. Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: correlation with smoking. Eur J Cancer Prev 2007;16(5):396-402
   Google Scholar
• Wan ES, Qiu W, Baccarelli A, et al. Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. Hum Mol Genet 2012;21(13):3073-82
   PubMed Web of Science ®Google Scholar
• Breitling LP, Yang R, Korn B, et al. Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 2011;88(4):450-7
   PubMed Web of Science ®Google Scholar
• Siedlinski M, Klanderman B, Sandhaus RA, et al. Association of cigarette smoking and CRP levels with DNA methylation in alpha-1 antitrypsin deficiency. Epigenetics 2012;7(7):720-8
   PubMed Web of Science ®Google Scholar
• Lam HC, Cloonan SM, Bhashyam AR, et al. Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction. J Clin Invest 2013;123(12):5212-30
   PubMed Web of Science ®Google Scholar
• Liu H, Zhou Y, Boggs SE, et al. Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B. Oncogene 2007;26(40):5900-10
   PubMed Web of Science ®Google Scholar
• Lin RK, Hsu HS, Chang JW, et al. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung cancer 2007;55(2):205-13
   PubMed Web of Science ®Google Scholar
• Lin RK, Hsieh YS, Lin P, et al. The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest 2010;120(2):521-32
   PubMed Web of Science ®Google Scholar
• Schwartz YB, Pirrotta V. A new world of Polycombs: unexpected partnerships and emerging functions. Nat Rev Genet 2013;14(12):853-64
   PubMed Web of Science ®Google Scholar
• Simon JA, Kingston RE. Occupying chromatin: polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Mol Cell 2013;49(5):808-24
   PubMed Web of Science ®Google Scholar
• Wolff EM, Liang G, Cortez CC, et al. RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking. Cancer Res 2008;68(15):6208-14
   PubMed Web of Science ®Google Scholar
• Xi S, Xu H, Shan J, et al. Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis. J Clin Invest 2013;123(3):1241-61
   PubMed Web of Science ®Google Scholar
• Hascher A, Haase AK, Hebestreit K, et al. DNA methyltransferase inhibition reverses epigenetically embedded phenotypes in lung cancer preferentially affecting polycomb target genes. Clin Cancer Res 2014;20(4):814-26
   PubMed Web of Science ®Google Scholar
• Reed MD, Tellez CS, Grimes MJ, et al. Aerosolised 5-azacytidine suppresses tumour growth and reprogrammes the epigenome in an orthotopic lung cancer model. Br J Cancer 2013;109(7):1775-81
   PubMed Web of Science ®Google Scholar
• Syed DN, Afaq F, Kweon MH, et al. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene 2007;26(5):673-82
   PubMed Web of Science ®Google Scholar
• Chan KH, Ho SP, Yeung SC, et al. Chinese green tea ameliorates lung injury in cigarette smoke-exposed rats. Respir Med 2009;103(11):1746-54
   PubMed Web of Science ®Google Scholar
• Helin K, Dhanak D. Chromatin proteins and modifications as drug targets. Nature 2013;502(7472):480-8
   PubMed Web of Science ®Google Scholar
• Grewal SI, Moazed D. Heterochromatin and epigenetic control of gene expression. Science 2003;301(5634):798-802
   PubMed Web of Science ®Google Scholar
• Feil R, Fraga MF. Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet 2011;13(2):97-109
   Web of Science ®Google Scholar
• Di Stefano A, Caramori G, Oates T, et al. Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J 2002;20(3):556-63
   PubMed Web of Science ®Google Scholar
• Szulakowski P, Crowther AJ, Jimenez LA, et al. The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174(1):41-50
   PubMed Web of Science ®Google Scholar
• Marwick JA, Kirkham PA, Stevenson CS, et al. Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am J Respir Cell Mol Biol 2004;31(6):633-42
   PubMed Web of Science ®Google Scholar
• Yang SR, Chida AS, Bauter MR, et al. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 2006;291(1):L46-57
   PubMed Web of Science ®Google Scholar
• Rahman I, Gilmour PS, Jimenez LA, MacNee W. Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol Cell Biochem 2002;234-235(1-2):239-48
   PubMed Web of Science ®Google Scholar
• Sundar IK, Chung S, Hwang JW, et al. Mitogen- and stress-activated kinase 1 (MSK1) regulates cigarette smoke-induced histone modifications on NF-kappaB-dependent genes. PLoS One 2012;7(2):e31378
   PubMedGoogle Scholar
• Ashburner BP, Westerheide SD, Baldwin AS Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 2001;21(20):7065-77
   PubMed Web of Science ®Google Scholar
• Chen L, Fischle W, Verdin E, Greene WC. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 2001;293(5535):1653-7
   PubMed Web of Science ®Google Scholar
• Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 2002;9(3):625-36
   PubMed Web of Science ®Google Scholar
• Chen Y, Huang P, Ai W, et al. Histone deacetylase activity is decreased in peripheral blood monocytes in patients with COPD. J Inflamm 2012;9:10
   Google Scholar
• Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005;352(19):1967-76
   PubMed Web of Science ®Google Scholar
• Isajevs S, Taivans I, Svirina D, et al. Patterns of inflammatory responses in large and small airways in smokers with and without chronic obstructive pulmonary disease. Respiration 2011;81(5):362-71
   PubMed Web of Science ®Google Scholar
• Mizuno S, Yasuo M, Bogaard HJ, et al. Inhibition of histone deacetylase causes emphysema. Am J Physiol Lung Cell Mol Physiol 2011;300(3):L402-13
   PubMed Web of Science ®Google Scholar
• Marwick JA, Caramori G, Stevenson CS, et al. Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. Am J Respir Crit Care Med 2009;179(7):542-8
   PubMed Web of Science ®Google Scholar
• Malhotra D, Thimmulappa RK, Mercado N, et al. Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients. J Clin Invest 2011;121(11):4289-302
   PubMed Web of Science ®Google Scholar
• To M, Takagi D, Akashi K, et al. Sputum plasminogen activator inhibitor-1 elevation by oxidative stress-dependent nuclear factor-kappaB activation in COPD. Chest 2013;144(2):515-21
   PubMed Web of Science ®Google Scholar
• Goven D, Boutten A, Lecon-Malas V, et al. Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema. Thorax 2008;63(10):916-24
   PubMed Web of Science ®Google Scholar
• Malhotra D, Thimmulappa R, Navas-Acien A, et al. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med 2008;178(6):592-604
   PubMed Web of Science ®Google Scholar
• Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature 2009;460(7255):587-91
   PubMed Web of Science ®Google Scholar
• Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 2012;13(4):225-38
   PubMed Web of Science ®Google Scholar
• Lavu S, Boss O, Elliott PJ, Lambert PD. Sirtuins – novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov 2008;7(10):841-53
   PubMed Web of Science ®Google Scholar
• Caito S, Rajendrasozhan S, Cook S, et al. SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J 2010;24(9):3145-59
   PubMed Web of Science ®Google Scholar
• Arunachalam G, Yao H, Sundar IK, et al. SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: role of resveratrol. Biochem Biophys Res Commun 2010;393(1):66-72
   PubMed Web of Science ®Google Scholar
• Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177(8):861-70
   PubMed Web of Science ®Google Scholar
• Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004;23(12):2369-80
   PubMed Web of Science ®Google Scholar
• Isajevs S, Strazda G, Kopeika U, Taivans I. Different patterns of lung sirtuin expression in smokers with and without chronic obstructive pulmonary disease. Medicina (B Aires) 2012;48(10):552-7
   Google Scholar
• Yao H, Chung S, Hwang JW, et al. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J Clin Invest 2012;122(6):2032-45
   PubMed Web of Science ®Google Scholar
• Nakamaru Y, Vuppusetty C, Wada H, et al. A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J 2009;23(9):2810-19
   PubMed Web of Science ®Google Scholar
• Yao H, Hwang JW, Sundar IK, et al. SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD. Am J Physiol Lung Cell Mol Physiol 2013;305(9):L615-24
   PubMed Web of Science ®Google Scholar
• Bakke PS, Zhu G, Gulsvik A, et al. Candidate genes for COPD in two large data sets. Eur Respir J 2011;37(2):255-63
   PubMed Web of Science ®Google Scholar
• Takasaka N, Araya J, Hara H, et al. Autophagy induction by SIRT6 through attenuation of insulin-like growth factor signaling is involved in the regulation of human bronchial epithelial cell senescence. J Immunol 2014;192(3):958-68
   PubMed Web of Science ®Google Scholar
• Barrero CA, Perez-Leal O, Aksoy M, et al. Histone 3.3 participates in a self-sustaining cascade of apoptosis that contributes to the progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;188(6):673-83
   PubMed Web of Science ®Google Scholar
• Sundar IK, Nevid MZ, Friedman AE, Rahman I. Cigarette smoke induces distinct histone modifications in lung cells: implications for the pathogenesis of COPD and lung cancer. J Proteome Res 2014;13(2):982-96
   PubMed Web of Science ®Google Scholar
• Hussain M, Rao M, Humphries AE, et al. Tobacco smoke induces polycomb-mediated repression of Dickkopf-1 in lung cancer cells. Cancer Res 2009;69(8):3570-8
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009;373(9678):1905-17
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 2013;131(3):636-45
   PubMed Web of Science ®Google Scholar
• Cosio BG, Tsaprouni L, Ito K, et al. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 2004;200(5):689-95
   PubMed Web of Science ®Google Scholar
• To Y, Ito K, Kizawa Y, et al. Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;182(7):897-904
   PubMed Web of Science ®Google Scholar
• Cosio BG, Iglesias A, Rios A, et al. Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD. Thorax 2009;64(5):424-9
   PubMed Web of Science ®Google Scholar
• Ford PA, Durham AL, Russell RE, et al. Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD. Chest 2010;137(6):1338-44
   PubMed Web of Science ®Google Scholar
• Mercado N, To Y, Ito K, Barnes PJ. Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase-delta. J Pharmacol Exp Ther 2011;337(2):465-70
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Wada H, Rossios C, et al. A novel macrolide/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via phosphoinositide 3-kinase pathway inhibition. Br J Pharmacol 2013;169(5):1024-34
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009;41(1):40-59
   PubMed Web of Science ®Google Scholar
• Meja KK, Rajendrasozhan S, Adenuga D, et al. Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am J Respir Cell Mol Biol 2008;39(3):312-23
   PubMed Web of Science ®Google Scholar
• Suzuki M, Betsuyaku T, Ito Y, et al. Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice. Am J Physiol Lung Cell Mol Physiol 2009;296(4):L614-23
   PubMed Web of Science ®Google Scholar
• Mercado N, Thimmulappa R, Thomas CM, et al. Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress. Biochem Biophys Res Commun 2011;406(2):292-8
   PubMed Web of Science ®Google Scholar
• Guan SP, Tee W, Ng DS, et al. Andrographolide protects against cigarette smoke-induced oxidative lung injury via augmentation of Nrf2 activity. Br J Pharmacol 2013;168(7):1707-18
   PubMed Web of Science ®Google Scholar
• Kumar V, Kumar S, Hassan M, et al. Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells. J Med Chem 2011;54(12):4147-59
   PubMed Web of Science ®Google Scholar
• Hwang TL, Leu YL, Kao SH, et al. Viscolin, a new chalcone from Viscum coloratum, inhibits human neutrophil superoxide anion and elastase release via a cAMP-dependent pathway. Free Radic Biol Med 2006;41(9):1433-41
   PubMed Web of Science ®Google Scholar
• Sinclair DA, Guarente L. Small-molecule allosteric activators of sirtuins. Annu Rev Pharmacol Toxicol 2014;54:363-80
   PubMed Web of Science ®Google Scholar
• Kode A, Rajendrasozhan S, Caito S, et al. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2008;294(3):L478-88
   PubMed Web of Science ®Google Scholar
• Knobloch J, Wahl C, Feldmann M, et al. Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic Acid in chronic obstructive pulmonary disease. Basic Clin Pharmacol Toxicol 2014;114(2):202-9
   PubMed Web of Science ®Google Scholar
• Nicodeme E, Jeffrey KL, Schaefer U, et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010;468(7327):1119-23
   PubMed Web of Science ®Google Scholar
• Lockwood WW, Zejnullahu K, Bradner JE, Varmus H. Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins. Proc Natl Acad Sci USA 2012;109(47):19408-13
   PubMed Web of Science ®Google Scholar
• Shimamura T, Chen Z, Soucheray M, et al. Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer. Clin Cancer Res 2013;19(22):6183-92
   PubMed Web of Science ®Google Scholar
• Okazaki Y, Furuno M, Kasukawa T, et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 2002;420(6915):563-73
   PubMed Web of Science ®Google Scholar
• Amaral PP, Mattick JS. Noncoding RNA in development. Mamm Genome 2008;19(7-8):454-92
   PubMed Web of Science ®Google Scholar
• Mariner PD, Walters RD, Espinoza CA, et al. Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol Cell 2008;29(4):499-509
   PubMed Web of Science ®Google Scholar
• Moazed D. Small RNAs in transcriptional gene silencing and genome defence. Nature 2009;457(7228):413-20
   PubMed Web of Science ®Google Scholar
• Castel SE, Martienssen RA. RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond. Nat Rev Genet 2013;14(2):100-12
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature 2004;431(7006):350-5
   PubMed Web of Science ®Google Scholar
• Pillai RS, Bhattacharyya SN, Artus CG, et al. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 2005;309(5740):1573-6
   PubMed Web of Science ®Google Scholar
• Nottrott S, Simard MJ, Richter JD. Human let-7a miRNA blocks protein production on actively translating polyribosomes. Nat Struct Mol Biol 2006;13(12):1108-14
   PubMed Web of Science ®Google Scholar
• Petersen CP, Bordeleau ME, Pelletier J, Sharp PA. Short RNAs repress translation after initiation in mammalian cells. Mol Cell 2006;21(4):533-42
   PubMed Web of Science ®Google Scholar
• Oglesby IK, McElvaney NG, Greene CM. MicroRNAs in inflammatory lung disease – master regulators or target practice? Respir Res 2010;11:148
   PubMed Web of Science ®Google Scholar
• O'Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 2011;11(3):163-75
   PubMed Web of Science ®Google Scholar
• Ezzie ME, Crawford M, Cho JH, et al. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax 2012;67(2):122-31
   PubMed Web of Science ®Google Scholar
• Van Pottelberge GR, Mestdagh P, Bracke KR, et al. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;183(7):898-906
   PubMed Web of Science ®Google Scholar
• De Flora S, Balansky R, D'Agostini F, et al. Smoke-induced microRNA and related proteome alterations. Modulation by chemopreventive agents. Int J Cancer 2012;131(12):2763-73
   PubMed Web of Science ®Google Scholar
• Izzotti A, Calin GA, Steele VE, et al. Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J 2009;23(9):3243-50
   PubMed Web of Science ®Google Scholar
• Hunninghake GM, Cho MH, Tesfaigzi Y, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med 2009;361(27):2599-608
   PubMed Web of Science ®Google Scholar
• Graff JW, Powers LS, Dickson AM, et al. Cigarette smoking decreases global microRNA expression in human alveolar macrophages. PLoS One 2012;7(8):e44066
   PubMed Web of Science ®Google Scholar
• Christenson SA, Brandsma CA, Campbell JD, et al. miR-638 regulates gene expression networks associated with emphysematous lung destruction. Genome Med 2013;5(12):114
   PubMed Web of Science ®Google Scholar
• Leidinger P, Keller A, Borries A, et al. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung cancer 2011;74(1):41-7
   PubMed Web of Science ®Google Scholar
• Akbas F, Coskunpinar E, Aynaci E, et al. Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease. Exp Lung Res 2012;38(6):286-94
   PubMed Web of Science ®Google Scholar
• Sanfiorenzo C, Ilie MI, Belaid A, et al. Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS One 2013;8(1):e54596
   PubMed Web of Science ®Google Scholar
• Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004;101(9):2999-3004
   PubMed Web of Science ®Google Scholar
• Davalos V, Moutinho C, Villanueva A, et al. Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene 2012;31(16):2062-74
   PubMed Web of Science ®Google Scholar
• Basma H, Gunji Y, Iwasawa S, et al. Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells. Am J Physiol Lung Cell Mol Physiol 2014;306(6):L552-65
   PubMed Web of Science ®Google Scholar
• Zhou Y, Kim J, Yuan X, Braun T. Epigenetic modifications of stem cells: a paradigm for the control of cardiac progenitor cells. Circ Res 2011;109(9):1067-81
   PubMed Web of Science ®Google Scholar
• Paschalaki KE, Starke RD, Hu Y, et al. Dysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased DNA damage and senescence. Stem Cells 2013;31(12):2813-26
   PubMed Web of Science ®Google Scholar
• Hoffmann G, Breitenbuecher F, Schuler M, Ehrenhofer-Murray AE. A novel SIRT2 inhibitor with p53-dependent pro-apoptotic activity in non-small-cell lung cancer. J Biol Chem 2014;289(8):5208-16
   PubMed Web of Science ®Google Scholar
• Giannini G, Cabri W, Fattorusso C, Rodriquez M. Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives. Future Med Chem 2012;4(11):1439-60
   PubMed Web of Science ®Google Scholar